4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-21-039928
Chairman and CEO gave up 37,350 shares (to pay taxes)
- Chairman and CEO acquired 12,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KAZIMI A J Chairman and CEO | 2021-03-17 | Shares withheld for taxes | −37,350 | $3.22 | $120,267 | 5,755,719 | D |
| KAZIMI A J Chairman and CEO | 2021-03-17 | Grant or award | +12,000 | $3.22 | $38,640 | 5,767,719 | D |
| Derivatives | |||||||
| KAZIMI A J Chairman and CEO | 2021-03-17 | Grant or award · Options (right to buy) | +88,000 | 88,000 | D | ||
Loading xslF345X03/doc4.xml…